New projections in the development of a vaccination model using two microorganisms and its application in leishmaniasis and leprosy
Interciencia
;
11(5): 239-41, sept.-oct. 1986. ilus, tab
Article
in English
| LILACS
| ID: lil-83457
ABSTRACT
Conventional vaccination is oriented toward the prevention of disease in individuals capable of developing normal immune responses. A new model of vaccination employing two microorganisms has been described for the correction of variable degrees of antigen-specifit deficiency in the development of effective cell-mediated immunity in two diseases, leprosy and cutaneous leishmaniasis, both of which are characterized by a spectrum of clinical manifestations. A schematic representation of the immunologic defect in the severe and progressive forms of these diseases and a possible mechanism for its correction using this vaccine model are presented. Immunotherapeutic and immunoprophylactic applications of the model are described, with particular reference to recent experience in the immunotherapy of localized cutaneous leishmaniasis. The efficacy, virtual absence of secondary effects, ease of administration and low cost of this therapeutic modality indicate that it offers an important option or field use in endemic of leishmaniasis
Search on Google
Index:
LILACS (Americas)
Main subject:
Leishmaniasis
/
Immunotherapy
/
Leprosy
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Interciencia
Journal subject:
Medicine
Year:
1986
Type:
Article
/
Project document
Similar
MEDLINE
...
LILACS
LIS